INSPIRE VETERINARY PARTNER - IVP STOCK NEWS

Inspire Veterinary Partners (Nasdaq:IVP) has appointed Samantha A. Ciulla as Director of Business Development. With over a decade of leadership experience in the veterinary sector, Ciulla will oversee business development, including market expansion, partnerships, and strategic acquisitions.

Ciulla joins IVP from Sterling Point Advisors, where she served as Managing Director. Her previous roles include Director of Partnership Development at Veterinary Practice Partners, Vice President of Veterinary Innovative Partners, and positions at VCA (now Mars Veterinary Health). She brings extensive experience in acquisition integration, relationship management, and strategic business development.

CEO Kimball Carr highlighted Ciulla's expertise in veterinary care and her relationships within the industry as key assets for developing IVP's acquisition and partnering strategy. Ciulla holds an MBA in Human Resource Management from Keller Graduate School of Management.

Inspire Veterinary Partners (Nasdaq:IVP) has announced a 1-for-25 reverse stock split effective January 27, 2025, at 12:01am Eastern Time. The split will reduce the company's authorized Common Stock from 36,998,148 to 1,479,926 shares, with corresponding adjustments to equity awards, warrants, and convertible notes.

The primary purpose of this reverse split is to achieve compliance with Nasdaq's $1.00 minimum bid price requirement to maintain listing. The stock will continue trading under the symbol 'IVP' with a new CUSIP number 45784E304. All stockholders' percentage interests remain unchanged, and fractional shares will be rounded up.

The board approved this decision on November 6, 2024, and as a Nevada , shareholder approval was not required since both authorized and outstanding shares are being proportionally reduced.

Inspire Veterinary Partners (IVP) reported Q3 2024 financial results showing total revenue of $4.0 million, a 1.7% decrease from the prior year. Service revenue increased 1% to $2.9 million, while product revenue declined 9% to $1.1 million. The company achieved significant cost reductions with G&A expenses decreasing 16% to $3.0 million. Net loss improved by 56% to $3.5 million compared to $7.9 million in the prior year. Post-quarter, IVP completed a registered direct offering raising $2.5 million through the sale of 10 million shares at $0.25 per share. Cash position as of September 30, 2024, was $0.68 million.

Inspire Veterinary Partners (Nasdaq:IVP), a U.S. pet health care services provider, has announced a $2.5 million registered direct offering of common stock. The company will sell 10,000,000 shares of Class A common stock at $0.25 per share to institutional investors. The offering is expected to close around October 23, 2024, subject to customary conditions.

Spartan Capital Securities, is acting as the sole placement agent. Inspire plans to use the net proceeds for working capital, general corporate purposes, strategic investments, and potential future acquisitions. The offering is based on an automatic shelf registration statement previously filed with the SEC. A prospectus supplement and accompanying base prospectus will be available on the SEC's website.

Inspire Veterinary Partners (NASDAQ:IVP) has entered a non-binding letter of intent to potentially acquire Vetsie.ai, an AI software platform for veterinary professionals, in an all-stock transaction. Vetsie.ai, backed by notable investors, aims to revolutionize pet healthcare by providing quick access to critical information. The potential acquisition aligns with Inspire's goal to innovate in pet care and integrate digital health into traditional workflows. The U.S. veterinarians market is expected to grow at a CAGR of 8.7% from 2023 to 2030. If realized, this acquisition could enhance Inspire's services and potentially generate new revenue streams through telehealth integration.

Inspire Veterinary Partners (NASDAQ:IVP) has announced plans to accelerate growth through acquisitions and expansion into new verticals within the pet care industry. The company aims to broaden its service offerings and enhance operations by implementing Artificial Intelligence (AI) tools. CEO Kimball Carr emphasized the company's commitment to advancing veterinary care and improving working conditions for veterinary professionals.

Key initiatives include:

• Expanding into eCommerce and pet technology
• Integrating AI for diagnostics, workflow automation, and practice management
• Seeking partnerships for pet care innovations
• Continuing acquisitions of pet care services businesses

These strategies aim to address challenges in the veterinary industry, potentially reducing workload, improving veterinarian-pet owner relationships, and tackling high turnover rates.

Inspire Veterinary Partners (Nasdaq: IVP) has nominated Phillip Balatsos as a new independent director for election at its annual stockholders meeting on October 9, 2024. Balatsos, currently Vice President of Foreign Exchange Emerging Markets Rates Sales/Trading at XP Investments US Inc., brings a diverse background in finance, hospitality, and public company board experience. His nomination aims to provide valuable perspectives for Inspire's strategic growth objectives.

Larry Alexander, Chair of the Nominating and Corporate Governance Committee, expressed confidence in Balatsos' potential contributions. Balatsos himself stated his alignment with Inspire's mission to improve pet lives and his eagerness to contribute to the company's future growth and success.

Inspire Veterinary Partners (NASDAQ:IVP) reported its Q2 2024 financial results, showing mixed performance. Total revenue decreased by 2% to $4.4 million compared to the prior year period. Services revenue increased by 1% to $3.2 million, while product revenue declined by 9% to $1.2 million. For the six-month period, total revenue increased by 5% to $9.2 million. The company made progress in reducing operating expenses, with Q2 2024 operating expenses down 11.8% compared to Q1 2024. Net loss increased to $3.4 million in Q2 2024 from $1.2 million in the prior year period. Inspire strengthened its balance sheet through a public offering after the quarter's end, aiming to provide financial flexibility for future growth.

Inspire Veterinary Partners (NASDAQ:IVP) has announced plans to accelerate its acquisition and growth strategy following a recent $6 million public offering. The company aims to expand its presence in the pet health and wellness marketplace, leveraging enhanced enterprise-wide systems and tools. Key growth initiatives include:

• Expanding through hospital acquisitions and new business integrations
• Scaling service offerings and national veterinary care footprint
• Diversifying earnings streams
• Building a differentiated merchandise offering
• Enhancing personalization capabilities using data-driven approaches

CEO Kimball Carr expressed confidence in the company's ability to drive strong growth and shareholder returns while maintaining financial discipline and focusing on revenue growth, gross margin expansion, and strong cash flow.